🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10470+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10470 recruiting trials

NARecruitingNCT06699394

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

👨‍⚕️ Jin Lu, M.D., Peking University People's Hospital📍 2 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06854653

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

🏥 Prescient Therapeutics, Ltd.📍 15 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06421675

Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma

👨‍⚕️ Hira Mian, MD, McMaster University📍 4 sites📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06620809

The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

👨‍⚕️ Dai-shi Tian, MD, Tongji Hospoital📍 1 site📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06822946

Zhibitai Capsules for the Treatment of Primary Hyperlipidemia

🏥 Chengdu Diao Jiuhong Pharmaceutical Factory📍 1 site📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT06795022

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

🏥 AstraZeneca📍 20 sites📅 Started Mar 2025View details ↗
EARLY_Phase 1RecruitingNCT06700070

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

👨‍⚕️ John Weinberg, MBBCH, Pure Biologics📍 1 site📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06655246

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

🏥 Kura Oncology, Inc.📍 32 sites📅 Started Mar 2025View details ↗
EARLY_Phase 1RecruitingNCT06002477

Attentional Mechanisms in SCD

👨‍⚕️ Paul Newhouse, MD, Vanderbilt University Medical Center📍 1 site📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06589804

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

👨‍⚕️ Siddharth Sheth, Alliance for Clinical Trials in Oncology📍 175 sites📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06644781

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

🏥 Daiichi Sankyo📍 88 sites📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT07136389

Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus

👨‍⚕️ Arina V Zinkina-Orikhan, PhD, Director of Clinical Development Department, BIOCAD📍 1 site📅 Started Mar 2025View details ↗
NARecruitingNCT06803745

Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) in Patients With Acute Leukemia Undergoing First Allogeneic Blood or Marrow Transplantation (BMT)

👨‍⚕️ Jonathan Webster, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins📍 1 site📅 Started Mar 2025View details ↗
Phase 2, PHASE3RecruitingNCT06126315

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

👨‍⚕️ Elisabetta Pupillo, PharmD, Istituto Di Ricerche Farmacologiche Mario Negri📍 19 sites📅 Started Mar 2025View details ↗
Phase 1, PHASE2RecruitingNCT07438067

EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

🏥 Daihong Liu📍 1 site📅 Started Mar 2025View details ↗
NARecruitingNCT07065604

Tubeless VATS for Mediastinal Neoplasm

🏥 Shuben Li📍 1 site📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT07473973

ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 Deficiency

👨‍⚕️ Medical Director, MD, BioMarin Pharmaceutical📍 8 sites📅 Started Mar 2025View details ↗
NARecruitingNCT06796543

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

👨‍⚕️ Sahaja Acharya, MD, SKCCC Johns Hopkins Medical Institution📍 2 sites📅 Started Mar 2025View details ↗
RecruitingNCT06856330

Effect of Furlow Palatoplasty With Buccal Myomucosal Flap on the Speech Development

🏥 Fayoum University📍 1 site📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT07029399

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

🏥 NiKang Therapeutics, Inc.📍 14 sites📅 Started Mar 2025View details ↗
← PreviousPage 131 of 524Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →